Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Drugs
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 151 - 165 of 345 items.
NAT-Bendamustine: Discoloration
RecallHealth product recall | 2022-12-06
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Teva-Atenolol; Product label image incorrect
RecallHealth product recall | 2022-11-21
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Children’s ibuprofen/acetaminophen shortage: What you should know and do
AlertPublic advisory | 2022-10-07
Menopur: Potential for a future out of specification result during shelf life
RecallHealth product recall | 2022-09-28
Lumi Lash: Unlicensed product with ingredient on prescription drug list.
RecallHealth product recall | 2022-09-26
Esomeprazole, Candesartan and Pravastatin Tablets: OOS result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
Menopur: Out of specification (Assay)
RecallHealth product recall | 2022-08-31
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27